Denosumab-associated jaw bone necrosis in cancer patients: retrospective descriptive case series study
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource, 1 online resource.
- Language
-
Englisch
- Bibliographic citation
-
Denosumab-associated jaw bone necrosis in cancer patients: retrospective descriptive case series study ; volume:45 ; number:1 ; day:30 ; month:6 ; year:2023 ; pages:1-10 ; date:12.2023
Maxillofacial plastic and reconstructive surgery ; 45, Heft 1 (30.6.2023), 1-10, 12.2023
- Creator
-
Kang, Ji-Yeon
Kim, Sang-Yup
Lim, Jae-Seok
Kim, Jwa-Young
Jin, Ga-Youn
Lee, Yeon-Jung
Lee, Eun-Young
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s40902-023-00391-9
- URN
-
urn:nbn:de:101:1-2023092911343396811149
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:57 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Kang, Ji-Yeon
- Kim, Sang-Yup
- Lim, Jae-Seok
- Kim, Jwa-Young
- Jin, Ga-Youn
- Lee, Yeon-Jung
- Lee, Eun-Young
- SpringerLink (Online service)
Other Objects (12)
Medication-related osteonecrosis of the jaw : bisphosphonates, denosumab, and new agents
Associated characteristics and treatment outcomes of medication-related osteonecrosis of the jaw in patients receiving denosumab or zoledronic acid for bone metastases
Switching from zoledronic acid to denosumab increases the risk for developing medication-related osteonecrosis of the jaw in patients with bone metastases
Risk evaluation of denosumab and zoledronic acid for medication-related osteonecrosis of the jaw in patients with bone metastases: a propensity score–matched analysis
Pseudomyogenic hemangioendothelioma of bone treated with denosumab: a case report
Risk factors associated with onset of medication-related osteonecrosis of the jaw in patients treated with denosumab
Long-term use of denosumab and its association with skeletal-related events and osteonecrosis of the jaw
Risk factors associated with onset of medication-related osteonecrosis of the jaw in patients treated with denosumab
JAW
Aneurysmal bone cyst: results of an off label treatment with Denosumab
Radiological findings of denosumab treatment for giant cell tumours of bone
Monostotic fibrous dysplasia of jaw bones: a case series
Medication-related osteonecrosis of the jaw : bisphosphonates, denosumab, and new agents
Associated characteristics and treatment outcomes of medication-related osteonecrosis of the jaw in patients receiving denosumab or zoledronic acid for bone metastases
Switching from zoledronic acid to denosumab increases the risk for developing medication-related osteonecrosis of the jaw in patients with bone metastases
Risk evaluation of denosumab and zoledronic acid for medication-related osteonecrosis of the jaw in patients with bone metastases: a propensity score–matched analysis
Pseudomyogenic hemangioendothelioma of bone treated with denosumab: a case report
Risk factors associated with onset of medication-related osteonecrosis of the jaw in patients treated with denosumab
Long-term use of denosumab and its association with skeletal-related events and osteonecrosis of the jaw
Risk factors associated with onset of medication-related osteonecrosis of the jaw in patients treated with denosumab
JAW
Aneurysmal bone cyst: results of an off label treatment with Denosumab
Radiological findings of denosumab treatment for giant cell tumours of bone
Monostotic fibrous dysplasia of jaw bones: a case series
Medication-related osteonecrosis of the jaw : bisphosphonates, denosumab, and new agents
Associated characteristics and treatment outcomes of medication-related osteonecrosis of the jaw in patients receiving denosumab or zoledronic acid for bone metastases
Switching from zoledronic acid to denosumab increases the risk for developing medication-related osteonecrosis of the jaw in patients with bone metastases
Risk evaluation of denosumab and zoledronic acid for medication-related osteonecrosis of the jaw in patients with bone metastases: a propensity score–matched analysis
Pseudomyogenic hemangioendothelioma of bone treated with denosumab: a case report
Risk factors associated with onset of medication-related osteonecrosis of the jaw in patients treated with denosumab
Long-term use of denosumab and its association with skeletal-related events and osteonecrosis of the jaw
Risk factors associated with onset of medication-related osteonecrosis of the jaw in patients treated with denosumab
JAW
Aneurysmal bone cyst: results of an off label treatment with Denosumab
Radiological findings of denosumab treatment for giant cell tumours of bone